Keith Finlayson

Director of Industrial Partnerships

Email: keith.finlayson@ed.ac.uk

Keith is currently the Director of Industrial Partnerships and has considerable experience in industrial and translational collaboration and commercialisation. In his previous role, he was the Head of the Business Development team in Edinburgh Innovations, leading a pan-university team for over 10 years, with a personal focus on drug discovery and transformative bio-medical technologies. Prior to this, Keith worked in industry for almost 20 years, including working with the Japanese Pharmaceutical company, Astellas, where he lead a team focussed on Alzheimer’s disease and neuro-degeneration/inflammation, covering bench to bedside activities from establishing in vitro high-throughput screens to conducting complex in vivo cognitive behavioural pharmacology. Prior to that he worked with GSK, focussing primarily on the role of inflammatory cells in lung disease including asthma.

Publications

 

Computational Fluorescence Suppression in Shifted Excitation Raman Spectroscopy (2023).
Jenkins N, Ehrlich K, Kufcsak A, Yerolatsitis S, Fernandes S, Young I, Hamilton K, Wood HA, Quinn T, Young V, Akram AR, Stone JM, Thomson RR, Finlayson K, Dhaliwal K, Seth S.

 

Specific in situ immuno-imaging of pulmonary-resident memory lymphocytes in human lungs (2023)

Humphries DC, O’Connor RA, Stewart HL, Quinn TM, Gaughan EE, Mills B, Williams GOS, Stone JM, Finlayson K,  Chabaud-Riou M, Boudet F, Dhaliwal K,  Pavot V.

 

Tri-mode optical biopsy probe with fluorescence endomicroscopy, Raman spectroscopy, and time-resolved fluorescence spectroscopy (2022).
Wood HA, Ehrlich K, Yerolatsitis S, Kufcsák A, Quinn TM, Fernandes S, Norberg D, Jenkins NC, Young V, Young I, Hamilton K, Seth S, Akram AR,Thomson RR, Finlayson K, Dhaliwal K, Stone JM.

 

Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics (2022).
Quinn T, Gaughan E E, Bruce A, Antonelli J, O’Connor R A, Li F, McNamara S, Koch O, Mackintosh C, Dockrell D, Walsh T, Blyth K G, Church C, Schwarze J, Boz C, Valanciute A, Burgess M, Emanuel P, Mills B, Rinaldi G, Hardisty G, Mills R, Findlay EG, Jabbal S, Duncan A, Plant S, Marshal ADL, Young I, Russell K, Scholefield E, Nimmo AF, Nazarov IB, Churchill GC, McCullagh JSO, Ebrahimi KH, Ferrett C, Templeton K, Rannard S, Owen A, Moore A, Finlayson K, Shankar-Hari M, Norrie J, Parker RA, Akram AR, Anthony DC, Dear JW, Hirani N, Dhaliwal K.

Skip to content